The Targeted Delivery Interest Group (TDIG) is a NIH multi-institutional team that champions targeted delivery of therapeutics to different organs for selective and effective treatments with reduced harmful effects. The group aims to identify gaps and opportunities to advance basic, translational, and clinical research for multiple delivery platforms applicable for the treatment of multiple diseases including autoimmunity, transplantation, cancers, neurodegeneration, cardiovascular diseases, and infectious diseases.
TDIG Monthly Webinar
The TDIG monthly webinar series will facilitate ideas exchanges and collaborations among academia, pharma, government, and the regulatory communities.
See the webinar schedule and information about past webinars.
TDIG Monthly Webinar Series is open to all.
Contact Information
Do you have any suggestions, or would you like to recommend a speaker? Contact us: